Description
ASTAL LABORATORIES LIMITED has listed 939,930 equity shares issued at Rs. 40 per share on preferential basis pursuant to warrant conversion, effective October 8, 2025.
Summary
BSE has announced the listing and trading commencement of 939,930 equity shares of ASTAL LABORATORIES LIMITED (Scrip Code: 512600) effective October 8, 2025. These shares were issued to Non-Promoters on a preferential basis pursuant to conversion of warrants at an issue price of Rs. 40 per share (Rs. 10 face value plus Rs. 30 premium).
Key Points
- 939,930 new equity shares of Rs. 10 each issued at premium of Rs. 30
- Shares issued to Non-Promoters on preferential basis through warrant conversion
- Trading permitted from Wednesday, October 8, 2025
- Distinctive Numbers: 9856371 to 10796300
- Shares rank pari-passu with existing equity shares
- ISIN: INE307N01014
- Scrip Code: 512600
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
- All 939,930 shares are subject to lock-in until April 30, 2026
- Trading members should note the lock-in restrictions when processing transactions
Important Dates
- Date of Allotment: August 12, 2025
- Trading Commencement: October 8, 2025
- Lock-in Expiry: April 30, 2026
Impact Assessment
This is a routine listing announcement with minimal market impact. The preferential issue represents a small capital raise through warrant conversion. The lock-in period until April 30, 2026 ensures no immediate selling pressure. The shares are issued to Non-Promoters and will rank equally with existing shares for all corporate actions and dividend rights.
Impact Justification
Routine listing of preferential shares from warrant conversion affecting less than 1 million shares with standard lock-in period